1. |
Mazur MT, Clark HB. Gastric stromal tumors. Reappraisal of histogenesis[J]. Am J Surg Pathol, 1983, 7(6):507-519.
|
2. |
CSCO胃肠间质瘤专家委员会.中国胃肠间质瘤诊断治疗专家共识(2011年版)[J].临床肿瘤学杂志, 2011, 16(9):836-844.
|
3. |
Lux ML, Rubin BP, Biase TL, et al. KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors[J]. Am J Pathol, 2000, 156(3):791-795.
|
4. |
Doyle LA, Hornick JL. Gastrointestinal stromal tumours:from KIT to succinate dehydrogenase[J]. Histopathology, 2014, 64(1):53-67.
|
5. |
Beadling C, Patterson J, Justusson E, et al. Gene expression of the IGF pathway family distinguishes subsets of gastrointestinal stromal tumors wild type for KIT and PDGFRA[J]. Cancer Med, 2013, 2(1):21-31.
|
6. |
王彦丽, 赵向荣, 白辰光, 等.胃肠道间质瘤组织中PDGFRα和C-kit基因突变和蛋白表达的关系[J].世界华人消化杂志, 2007, 15(21):2300-2305.
|
7. |
Miettinen M, Monihan JM, Sarlomo-Rikala M, et al. Gastrointestinal stromal tumors/smooth muscle tumors (GISTs) primary in the omentum and mesentery:clinicopathologic and immunohistochemical study of 26 cases[J]. Am J Surg Pathol, 1999, 23(9): 1109-1118.
|
8. |
Heinrich MC, Rubin BP, Longley BJ, et al. Biology and genetic aspects of gastrointestinal stromal tumors:KIT activation and cytogenetic alterations[J]. Hum Pathol, 2002, 33(5):484-495.
|
9. |
Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors presenting as omental masses-A clinicopathologic analysis of 95 cases[J]. Am J Surg Pathol, 2009, 33(9):1267-1275.
|
10. |
Miettinen M, Makhlouf H, Sobin LH, et al. Gastrointestinal stromal tumors of the jejunum and ileum-A clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up[J]. Am J Surg Pathol, 2006, 30(4):477-489.
|
11. |
Corless CL, Schroeder A, Griffith D, et al. PDGFRA mutations in gastrointestinal stromal tumors:frequency, spectrum and in vitro sensitivity to imatinib[J]. J Clin Oncol, 2005, 23(23): 5357-5364.
|
12. |
Lamba G, Gupta R, Lee B, et al. Current management and prognostic features for gastrointestinal stromal tumor (GIST)[J]. Exp Hematol Oncol, 2012, 1(1):14.
|
13. |
Beham AW, Schaefer IM, Schüler P, et al. Gastrointestinal stromal tumors[J]. Int J Colorectal Dis, 2012, 27(6):689-700.
|
14. |
Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach-A clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up[J]. Am J Surg Pathol, 2005, 29(1):52-68.
|
15. |
张启瑜.钱礼腹部外科学[M].北京:人民卫生出版社, 2006: 230-231.
|
16. |
杨弘鑫, 陈秀峰, 张波, 等. 217例胃间质瘤的临床特点与诊治[J].中国普外基础与临床杂志, 2012, 19(9):951-956.
|
17. |
胡月颖.胃肠道间质瘤的影像学诊断[J].医学理论与实践, 2013, 26(11):1440-1442.
|
18. |
宗春华, 徐雷鸣, 陈惠芳.内镜超声检查术在胃间质瘤中的诊断价值[J].中国内镜杂志, 2006, 12(9):917-918, 921.
|
19. |
李建卫, 吴松松, 朱琳, 等.彩色多普勒超声鉴别诊断胃间质瘤与胃癌[J].中国医学影像技术, 2011, 27(6):1227-1230.
|
20. |
郑育聪, 李健丁, 张瑞平.胃肠道间质瘤的影像学研究进展[J].世界华人消化杂志, 2010, 18(1):49-53.
|
21. |
李成明, 张瑜, 祝青松, 等. CT诊断胃间质瘤[J].中国医学影像学杂志, 2008, 16(2):145-146.
|
22. |
易亚辉, 周建胜.胃间质瘤的CT和MRI诊断[J].中国医学影像学杂志, 2006, 14(5):336-340.
|
23. |
Levy AD, Remotti HE, Thompson WM, et al. Gastrointestinal stromal tumors:radiologic features with pathologic correlation[J]. Radiographics, 2003, 23(2):283-304, 456.
|
24. |
刘长青, 谭诗云, 李军华, 等.超声内镜联合CT对胃间质瘤的临床诊断价值[J].世界华人消化杂志, 2012, 20(25):2404-2406.
|
25. |
王钧. 32例胃肠道间质瘤的病理学及免疫组化研究[J].当代医学, 2012, 18(12):4-5.
|
26. |
哈英娣, 李青清, 苏勤军, 等.胃间质瘤的临床病理改变[J].现代肿瘤医学, 2008, 16(8):1346-1348.
|
27. |
戎龙, 万远廉, 年卫东, 等.胃间质瘤63例临床分析[J].中华胃肠外科杂志, 2009, 12(1):24-27.
|
28. |
Espinosa I, Lee CH, Kim MK, et al. A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors[J]. Am J Surg Pathol, 2008, 32(2): 210-218.
|
29. |
王卓才, 赖日权, 黄小让, 等.胃间质瘤CD34, SMA, S-100蛋白表达与细胞增殖和预后关系[J].广东医学, 2002, 23(8): 823-824.
|
30. |
Tsujimura T, Makiishi-Shimobayashi C, Lundkvist J, et al. Expression of the intermediate filament nestin in gastrointestinal stromal tumors and interstitial cells of Cajal[J]. Am J Pathol, 2001, 158(3):817-823.
|
31. |
Kang KY, Lee W. Gastrointestinal stromal tumor with extensive lymphatic metastasis:a case report[J]. J Gastric Cancer, 2013, 13(3):192-195.
|
32. |
何裕隆.胃肠间质瘤临床病例解析[J].国际外科学杂志, 2007, 34(5):354-358.
|
33. |
Dematteo RP, Ballman KV, Antonescu CR, et al. Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour:a randomised, double-blind, placebocontrolled trial[J]. Lancet, 2009, 373(9669):1097-1104.
|
34. |
熊炳贤, 李红浪, 曾飞, 等.胃间质细胞瘤18例诊治分析[J].中国普通外科杂志, 2004, 13(9):670-672.
|
35. |
柴宇啸, 曲兴龙, 李雷, 等.胃间质瘤16例诊治分析[J].中国普通外科杂志, 2009, 18(10):1091-1093.
|
36. |
师英强, 杜春燕, 周烨, 等.胃肠间质瘤联合脏器切除22例疗效分析[J].中国实用外科杂志, 2008, 28(4):273-274.
|
37. |
魏志刚, 韩超, 李健丁.胃肠道间质瘤的诊断治疗[J].世界华人消化杂志, 2010, 18(1):65-69.
|
38. |
Winfield RD, Hochwald SN, Vogel SB, et al. Presentation and management of gastrointestinal stromal tumors of the duodenum[J]. Am Surg, 2006, 72(8):719-723.
|
39. |
陈凛, 李涛.十二指肠间质瘤临床诊断与治疗[J].中国实用外科杂志, 2008, 28(11):945-946.
|
40. |
何裕隆.胃肠间质瘤外科治疗的选择[J].中华胃肠外科杂志, 2006, 9(1):15-16.
|
41. |
师英强, 杜春燕.胃肠间质瘤的外科治疗问题[J].肿瘤研究与临床, 2006, 18(8):518-520.
|
42. |
张旭, 戎铁华, 吴秋良, 等.食管间质瘤与平滑肌肿瘤的临床鉴别及治疗[J].癌症, 2006, 25(7):901-905.
|
43. |
Hornick LJ, Fletcher CD. The role of KIT in the management of patients with gastrointestinal stromal tumors[J]. Hum Pathol, 2007, 38(5):679-687.
|
44. |
张文, 陈治宇, 王磊苹, 等.伊马替尼治疗晚期胃肠道间质瘤[J].中国癌症杂志, 2008, 18(1):42-45.
|
45. |
Zalcberg JR, Verweij J, Casali PG, et al. Outcome of patients with advanced gastrointestinal stromal tumours crossing over to a daily imatinib dose of 800 mg after progression on 400 mg[J]. Eur J Cancer, 2005, 41(12):1751-1757.
|
46. |
周辛欣, 季峰.胃肠道间质瘤分子靶向治疗研究进展[J].国际消化病杂志, 2009, 29(5):346-348.
|
47. |
王春萌, 师英强, 傅红, 等.甲磺酸伊马替尼治疗胃肠道间质瘤的疗效及安全性分析[J].中国癌症杂志, 2008, 18(11): 873-875.
|
48. |
Demetri GD, van Oosterom AT, Garrett CR, et al. Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib:a randomised controlled trial[J]. Lancet, 2006, 368(9544):1329-1338.
|
49. |
Kefeli U, Benekli M, Sevinc A, et al. Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third-or fourth-line treatment:A retrospective multicenter experience[J]. Oncol Lett, 2013, 6(2):605-611.
|
50. |
李嘉, 李昂, 张钰鹏, 等.胃肠间质瘤并广泛转移[J].中国实用外科杂志, 2011, 31(2):183-185.
|
51. |
高志冬, 叶颖江, 全美盈, 等.胃肠间质瘤肝转移诊治进展[J].中国实用外科杂志, 2009, 29(8):693-696.
|
52. |
Joensuu H. Risk stratification of patients diagnosed with gastrointestinal stromal tumor[J]. Hum Pathol, 2008, 39(10):1411-1419.
|
53. |
李增辉, 秦岭, 李荣, 等. 212例胃肠间质瘤的临床病理特征及预后分析[J].热带医学杂志, 2012, 12(5):542-546, 565.
|
54. |
Wada N, Kurokawa Y, Nishida T, et al. Subgroups of patients with very large gastrointestinal stromal tumors with distinct prognoses:a multicenter study[J]. J Surg Oncol, 2014, 109(2): 67-70.
|
55. |
Yang H, Shen C, Zhang B, et al. Expression and clinicopathological significance of CD9 in gastrointestinal stromal tumor[J]. J Korean Med Sci, 2013, 28(10):1443-1448.
|
56. |
肖钟迪, 曹宏, 金洪永, 等.胃肠道间质细胞瘤CD117、Nestin和Ki-67表达及其临床意义[J/CD].中华普外科手术学杂志:电子版, 2008, 2(1):103-109.
|